BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6848750)

  • 1. Role of protein binding in cocaine-induced hepatic necrosis.
    Evans MA
    J Pharmacol Exp Ther; 1983 Jan; 224(1):73-9. PubMed ID: 6848750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic activation of furosemide to a chemically reactive, hepatotoxic metabolite.
    Mitchell JR; Nelson WL; Potter WZ; Sasame HA; Jollow DJ
    J Pharmacol Exp Ther; 1976 Oct; 199(1):41-52. PubMed ID: 978483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An epoxysuccinic acid derivative(loxistatin)-induced hepatic injury in rats and hamsters.
    Fukushima K; Arai M; Kohno Y; Suwa T; Satoh T
    Toxicol Appl Pharmacol; 1990 Aug; 105(1):1-12. PubMed ID: 2392799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of cytochrome P-450IIB1 as a cocaine-bioactivating isoform in rat hepatic microsomes and in cultured rat hepatocytes.
    Boelsterli UA; Lanzotti A; Göldlin C; Oertle M
    Drug Metab Dispos; 1992; 20(1):96-101. PubMed ID: 1347004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cytochrome P450 inducers on cocaine-mediated hepatotoxicity.
    Bornheim LM
    Toxicol Appl Pharmacol; 1998 May; 150(1):158-65. PubMed ID: 9630465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human microsomal N-oxidative metabolism of cocaine.
    Roberts SM; Harbison RD; James RC
    Drug Metab Dispos; 1991; 19(6):1046-51. PubMed ID: 1687009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver toxicity from norcocaine nitroxide, an N-oxidative metabolite of cocaine.
    Ndikum-Moffor FM; Schoeb TR; Roberts SM
    J Pharmacol Exp Ther; 1998 Jan; 284(1):413-9. PubMed ID: 9435205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cocaine hepatotoxicity: influence of hepatic enzyme inducing and inhibiting agents on the site of necrosis.
    Roth L; Harbison RD; James RC; Tobin T; Roberts SM
    Hepatology; 1992 May; 15(5):934-40. PubMed ID: 1568735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Norcocaine nitroxide. A potential hepatotoxic metabolite of cocaine.
    Rauckman EJ; Rosen GM; Cavagnaro J
    Mol Pharmacol; 1982 Mar; 21(2):458-63. PubMed ID: 7099146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practolol metabolism. III. Irreversible binding of [14C]practolol metabolite(s) to mammalian liver microsomes.
    Orton TC; Lowery C
    J Pharmacol Exp Ther; 1981 Oct; 219(1):207-12. PubMed ID: 6793710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic activation of trichloroethylene into a chemically reactive metabolite toxic to the liver.
    Allemand H; Pessayre D; Descatoire V; DeGott C; Feldmann G; Benhamou JP
    J Pharmacol Exp Ther; 1978 Mar; 204(3):714-23. PubMed ID: 633075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of phencyclidine pretreatment on cocaine-mediated hepatotoxicity in mice.
    Reid MJ; Bornheim LM
    Toxicol Appl Pharmacol; 2001 May; 172(3):194-202. PubMed ID: 11312647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High affinity binding of [3H] cocaine to rat liver microsomes.
    el-Maghrabi EA; Calligaro DO; Eldefrawi ME
    Life Sci; 1988; 42(17):1675-82. PubMed ID: 3367687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regenerative changes in hepatic morphology and enhanced expression of CYP2B10 and CYP3A during daily administration of cocaine.
    Pellinen P; Stenbäck F; Kojo A; Honkakoski P; Gelboin HV; Pasanen M
    Hepatology; 1996 Mar; 23(3):515-23. PubMed ID: 8617431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of the cytochrome P450 mechanism-based inhibitor N-benzyl-1-aminobenzotriazole to products that covalently bind with protein in guinea pig liver and lung microsomes: comparative study with 1-aminobenzotriazole.
    Woodcroft KJ; Webb CD; Yao M; Weedon AC; Bend JR
    Chem Res Toxicol; 1997 May; 10(5):589-99. PubMed ID: 9168258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic analysis of the metabolism of cocaine to norcocaine and N-hydroxynorcocaine in mice.
    Boyer CS; Petersen DR
    Drug Metab Dispos; 1992; 20(6):863-8. PubMed ID: 1362939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of acetaminophen and cocaine hepatotoxicity in mice by cimetidine treatment.
    Peterson FJ; Knodell RG; Lindemann NJ; Steele NM
    Gastroenterology; 1983 Jul; 85(1):122-9. PubMed ID: 6852446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex and strain differences in response to cocaine.
    Thompson ML; Shuster L; Casey E; Kanel GC
    Biochem Pharmacol; 1984 Apr; 33(8):1299-307. PubMed ID: 6712735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Participation of cytochromes P4502B and P4503A in cocaine toxicity in rat hepatocytes.
    Poet TS; McQueen CA; Halpert JR
    Drug Metab Dispos; 1996 Jan; 24(1):74-80. PubMed ID: 8825193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of cocaine metabolism in primary rat hepatocyte cultures: effects on irreversible binding and protein biosynthesis.
    Bouis P; Boelsterli UA
    Toxicol Appl Pharmacol; 1990 Jul; 104(3):429-39. PubMed ID: 2385835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.